Faeth Therapeutics, Inc. Common Stock

FTH XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

730M

Short interest (Jul 15)

3.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

64.47%

↓ 29.7%

Available Shares

↑ 12.7%

Price Chart

Company Overview

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001829802

Asset Type: CS

Market Data

Market Cap: $729,280,950

Employees: 29

Status: Active

Short Interest

Current Borrow Fee 64.47%

Range: 64.47% - 64.47%

Available Shares 1M

Range: 550K - 1M

Recent Changes

Fee Change: ↓ 14.2%

Available Change: ↓ 3.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime